These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7890234)

  • 1. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.
    Mitsuyama K; Toyonaga A; Sasaki E; Ishida O; Ikeda H; Tsuruta O; Harada K; Tateishi H; Nishiyama T; Tanikawa K
    Gut; 1995 Jan; 36(1):45-9. PubMed ID: 7890234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease.
    Mitsuyama K; Tomiyasu N; Suzuki A; Takaki K; Takedatsu H; Masuda J; Yamasaki H; Matsumoto S; Tsuruta O; Toyonaga A; Sata M
    Clin Exp Immunol; 2006 Jan; 143(1):125-31. PubMed ID: 16367943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
    Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
    J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity.
    Nancey S; Hamzaoui N; Moussata D; Graber I; Bienvenu J; Flourie B
    Dig Dis Sci; 2008 Jan; 53(1):242-7. PubMed ID: 17549633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.
    Mazlam MZ; Hodgson HJ
    Gut; 1994 Jan; 35(1):77-83. PubMed ID: 8307455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
    Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
    Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.
    Mahida YR; Kurlac L; Gallagher A; Hawkey CJ
    Gut; 1991 Dec; 32(12):1531-4. PubMed ID: 1773961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
    Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
    Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.
    Salvi M; Girasole G; Pedrazzoni M; Passeri M; Giuliani N; Minelli R; Braverman LE; Roti E
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2976-9. PubMed ID: 8768861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin 6 receptor in biological fluids from human origin.
    Frieling JT; Sauerwein RW; Wijdenes J; Hendriks T; van der Linden CJ
    Cytokine; 1994 Jul; 6(4):376-81. PubMed ID: 7948745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.
    Brynskov J; Tvede N; Andersen CB; Vilien M
    Gut; 1992 Jan; 33(1):55-8. PubMed ID: 1740278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF
    Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease.
    Hyams JS; Fitzgerald JE; Wyzga N; Treem WR; Justinich CJ; Kreutzer DL
    Dig Dis Sci; 1994 Sep; 39(9):1893-9. PubMed ID: 8082495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circulating common gamma chain (CD132) in inflammatory bowel disease.
    Nielsen OH; Kirman I; Johnson K; Giedlin M; Ciardelli T
    Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
    Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
    Transplantation; 1996 Jul; 62(1):138-42. PubMed ID: 8693533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.